From Glasgow University this morning on new strategy for treatment of pancreatic cancer:
Our study is a huge breakthrough in terms of what might be possible with future treatments. As part of our research, the strategy we’ve developed is extremely promising, and we’re very pleased and proud to see it now be taken into clinical trial. For us, this is a demonstration of a bench-to-bedside precision oncology approach to tackle this terrible disease.
Dr David Chang, University of Glasgow Institute of Cancer Sciences:
Pancreatic cancer is one of few cancers where survival rates have not improved dramatically in recent decades.